The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib/II study of an IL-2/T-cell receptor fusion protein in combination with gemcitabine and cisplatin in advanced or metastatic chemo-refractory urothelial cancer (UC).
 
Mayer N. Fishman
Honoraria - Dendreon
Consulting or Advisory Role - Bayer; Medivation
Speakers' Bureau - GlaxoSmithKline; Prometheus
Research Funding - Acceleron Pharma; Bristol-Myers Squibb; Dendreon; Eisai; Exelixis; GlaxoSmithKline; Pfizer; TRACON Pharma
 
Daniel A. Vaena
Consulting or Advisory Role - Bayer
Research Funding - Altor BioScience (Inst); Argos Therapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Tekmira (Inst); Threshold Pharmaceuticals (Inst)
 
Parminder Singh
No Relationships to Disclose
 
Joel Picus
No Relationships to Disclose
 
Ulka N. Vaishampayan
Honoraria - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Research Funding - Astellas Pharma; Exelixis; Novartis
 
Joel Slaton
No Relationships to Disclose
 
John Francis Mahoney
Stock and Other Ownership Interests - Emergent BioSolutions; Exelixis; Rexahn Pharmaceuticals
 
Sanjiv S Agarwala
No Relationships to Disclose
 
Charles Joel Rosser
No Relationships to Disclose
 
Danny Landau
Honoraria - MDLinx
Speakers' Bureau - Astellas Pharma; Celgene
 
Julio Hajdenberg
Speakers' Bureau - Astellas Pharma; Celgene; Incyte; Janssen Oncology; Novartis
 
Peter J. Van Veldhuizen
Research Funding - Altor BioScience
 
Rahul Atul Parikh
Stock and Other Ownership Interests - Gilead Sciences (I)
 
Sarah Alter
Employment - Altor BioScience
 
Liza Hernandez
Employment - Altor BioScience
Stock and Other Ownership Interests - Altor BioScience
 
Peter Rhode
Employment - Altor BioScience
Leadership - Altor BioScience
Stock and Other Ownership Interests - Altor BioScience
Patents, Royalties, Other Intellectual Property - Altor BioScience
 
Hing C. Wong
Employment - Altor BioScience
Leadership - Altor BioScience
Stock and Other Ownership Interests - Altor BioScience
Patents, Royalties, Other Intellectual Property - Altor BioScience